accountTargeting Drug Delivery System (NTDDS).The company has also out-licensed the use of GAD for the treatment of Parkinson's disease. The company currently has three clinical-phase products. Diamyd Medical has offices in Sweden and in the U.S. Shares are...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Diamyd's New Share Issue Substantially Oversubscribed
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
